N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Strategies to eliminate reactive metabolites-Reference-Cited by-同舟云学术

N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Strategies to eliminate reactive metabolites

Published:2013-04 Issue:8 Volume:23 Page:2344-2348
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Nair Sajiv K.,Matthews Jean J.,Cripps Stephan J.,Cheng Hengmiao,Hoffman Jacqui E.,Smith Christopher,Kupchinsky Stanley,Siu Michael,Taylor Wendy D.,Wang Yong,Johnson Theodore O.,Dress Klaus R.,Edwards Martin P.,Zhou Sue,Hosea Natilie A.,LaPaglia Amy,Kang Ping,Castro Arturo,Ermolieff Jacques,Fanjul Andrea,Vogel Jennifer E.,Rejto Paul,Dalvie Deepak

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference20 articles.

1. 11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory

2. 11β-Hydroxysteroid dehydrogenases: Key enzymes in determining tissue-specific glucocorticoid effects

3. Minireview: 11β-Hydroxysteroid Dehydrogenase Type 1— A Tissue-Specific Amplifier of Glucocorticoid Action1

4. Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes

5. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective Application of Metabolite Profiling in Drug Design and Discovery;Journal of Medicinal Chemistry;2020-02-25

2. Mechanistic Insight on the Mode of Action of Colletoic Acid;Journal of Medicinal Chemistry;2019-07-11

3. Biaryls;Privileged Structures in Drug Discovery;2018-03-09

4. Intermolecular Amidation of Quinoline N-Oxides with Arylsulfonamides under Metal-Free Conditions;Organic Letters;2017-11-02

5. Detecting reactive drug metabolites for reducing the potential for drug toxicity;Expert Opinion on Drug Metabolism & Toxicology;2015-05-25